Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands |
Total |
Common Shares |
Class B Common Stock |
Common Stock
Common Shares
|
Common Stock
Class B Common Stock
|
Capital Surplus |
Retained Earnings |
Retained Earnings
Common Shares
|
Retained Earnings
Class B Common Stock
|
Accumulated Other Comprehensive Loss |
| Beginning balance (in shares) at Aug. 31, 2024 |
|
|
|
|
15,000
|
3,590
|
|
|
|
|
|
| Beginning balance at Aug. 31, 2024 |
|
$ 2,108,511
|
|
|
$ 1,500
|
$ 359
|
$ 104,791
|
$ 2,025,505
|
|
|
$ (23,644)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
43,105
|
|
|
|
|
|
43,105
|
|
|
|
| Change in fair value of derivatives |
[1] |
41
|
|
|
|
|
|
|
|
|
41
|
| Foreign currency translation |
|
(4,936)
|
|
|
|
|
|
|
|
|
(4,936)
|
| Dividends declared Common Stock |
|
|
$ (5,260)
|
$ (996)
|
|
|
|
|
$ (5,260)
|
$ (996)
|
|
| Repurchase of Common Stock (in shares) |
|
|
|
|
(34)
|
|
|
|
|
|
|
| Repurchase of Common Stock |
|
(6,373)
|
|
|
$ (3)
|
|
(235)
|
(6,135)
|
|
|
|
| Share-based compensation, net |
[2] |
(448)
|
|
|
|
|
(448)
|
|
|
|
|
| Share-based awards exercised, net (in shares) |
[1] |
|
|
|
33
|
|
|
|
|
|
|
| Share-based awards exercised, net |
[1] |
3
|
|
|
$ 3
|
|
|
|
|
|
|
| Shares Converted (in shares) |
|
|
|
|
32
|
(32)
|
|
|
|
|
|
| Shares Converted |
|
0
|
|
|
$ 3
|
$ (3)
|
|
|
|
|
|
| Ending balance (in shares) at Nov. 30, 2024 |
|
|
|
|
15,031
|
3,558
|
|
|
|
|
|
| Ending balance at Nov. 30, 2024 |
|
2,133,647
|
|
|
$ 1,503
|
$ 356
|
104,108
|
2,056,219
|
|
|
(28,539)
|
| Beginning balance (in shares) at Aug. 31, 2024 |
|
|
|
|
15,000
|
3,590
|
|
|
|
|
|
| Beginning balance at Aug. 31, 2024 |
|
2,108,511
|
|
|
$ 1,500
|
$ 359
|
104,791
|
2,025,505
|
|
|
(23,644)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
107,244
|
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at May. 31, 2025 |
|
|
|
|
14,936
|
3,553
|
|
|
|
|
|
| Ending balance at May. 31, 2025 |
|
2,174,791
|
|
|
$ 1,494
|
$ 355
|
108,486
|
2,088,873
|
|
|
(24,417)
|
| Beginning balance (in shares) at Nov. 30, 2024 |
|
|
|
|
15,031
|
3,558
|
|
|
|
|
|
| Beginning balance at Nov. 30, 2024 |
|
2,133,647
|
|
|
$ 1,503
|
$ 356
|
104,108
|
2,056,219
|
|
|
(28,539)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
24,459
|
|
|
|
|
|
24,459
|
|
|
|
| Change in fair value of derivatives |
[1] |
25
|
|
|
|
|
|
|
|
|
25
|
| Foreign currency translation |
|
(4,438)
|
|
|
|
|
|
|
|
|
(4,438)
|
| Dividends declared Common Stock |
|
|
(5,251)
|
(996)
|
|
|
|
|
(5,251)
|
(996)
|
|
| Repurchase of Common Stock (in shares) |
|
|
|
|
(33)
|
|
|
|
|
|
|
| Repurchase of Common Stock |
|
(6,155)
|
|
|
$ (3)
|
|
(231)
|
(5,921)
|
|
|
|
| Share-based compensation, net |
[2] |
2,264
|
|
|
|
|
2,264
|
|
|
|
|
| Share-based awards exercised, net (in shares) |
[1] |
|
|
|
8
|
|
|
|
|
|
|
| Share-based awards exercised, net |
[1] |
1
|
|
|
$ 1
|
|
|
|
|
|
|
| Ending balance (in shares) at Mar. 01, 2025 |
|
|
|
|
15,006
|
3,558
|
|
|
|
|
|
| Ending balance at Mar. 01, 2025 |
|
2,143,556
|
|
|
$ 1,501
|
$ 356
|
106,141
|
2,068,510
|
|
|
(32,952)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
39,680
|
|
|
|
|
|
39,680
|
|
|
|
| Change in fair value of derivatives |
[1] |
(84)
|
|
|
|
|
|
|
|
|
(84)
|
| Foreign currency translation |
|
8,619
|
|
|
|
|
|
|
|
|
8,619
|
| Dividends declared Common Stock |
|
|
(5,227)
|
(995)
|
|
|
|
|
(5,227)
|
(995)
|
|
| Repurchase of Common Stock (in shares) |
|
|
|
|
(76)
|
|
|
|
|
|
|
| Repurchase of Common Stock |
|
(13,634)
|
|
|
$ (8)
|
|
(531)
|
(13,095)
|
|
|
|
| Share-based compensation, net |
[2] |
2,876
|
|
|
|
|
2,876
|
|
|
|
|
| Share-based awards exercised, net (in shares) |
[1] |
|
|
|
1
|
|
|
|
|
|
|
| Shares Converted (in shares) |
|
|
|
|
5
|
(5)
|
|
|
|
|
|
| Shares Converted |
|
0
|
|
|
$ 1
|
$ (1)
|
|
|
|
|
|
| Ending balance (in shares) at May. 31, 2025 |
|
|
|
|
14,936
|
3,553
|
|
|
|
|
|
| Ending balance at May. 31, 2025 |
|
2,174,791
|
|
|
$ 1,494
|
$ 355
|
108,486
|
2,088,873
|
|
|
(24,417)
|
| Beginning balance (in shares) at Aug. 30, 2025 |
|
|
|
|
14,679
|
3,551
|
|
|
|
|
|
| Beginning balance at Aug. 30, 2025 |
|
2,168,957
|
|
|
$ 1,468
|
$ 355
|
109,107
|
2,079,812
|
|
|
(21,785)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
34,363
|
|
|
|
|
|
34,363
|
|
|
|
| Change in fair value of derivatives |
[1] |
(2)
|
|
|
|
|
|
|
|
|
(2)
|
| Foreign currency translation |
|
(2,105)
|
|
|
|
|
|
|
|
|
(2,105)
|
| Dividends declared Common Stock |
|
|
(5,300)
|
(1,038)
|
|
|
|
|
(5,300)
|
(1,038)
|
|
| Repurchase of Common Stock (in shares) |
|
|
|
|
(194)
|
|
|
|
|
|
|
| Repurchase of Common Stock |
|
(31,674)
|
|
|
$ (19)
|
|
(1,443)
|
(30,212)
|
|
|
|
| Share-based compensation, net |
[2] |
(606)
|
|
|
|
|
(606)
|
|
|
|
|
| Share-based awards exercised, net (in shares) |
[1] |
|
|
|
34
|
|
|
|
|
|
|
| Share-based awards exercised, net |
[1] |
3
|
|
|
$ 3
|
|
|
|
|
|
|
| Ending balance (in shares) at Nov. 29, 2025 |
|
|
|
|
14,519
|
3,551
|
|
|
|
|
|
| Ending balance at Nov. 29, 2025 |
|
2,162,598
|
|
|
$ 1,452
|
$ 355
|
107,058
|
2,077,625
|
|
|
(23,892)
|
| Beginning balance (in shares) at Aug. 30, 2025 |
|
|
|
|
14,679
|
3,551
|
|
|
|
|
|
| Beginning balance at Aug. 30, 2025 |
|
2,168,957
|
|
|
$ 1,468
|
$ 355
|
109,107
|
2,079,812
|
|
|
(21,785)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
74,763
|
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at May. 30, 2026 |
|
|
|
|
14,532
|
3,551
|
|
|
|
|
|
| Ending balance at May. 30, 2026 |
|
2,198,045
|
|
|
$ 1,453
|
$ 355
|
112,621
|
2,105,352
|
|
|
(21,736)
|
| Beginning balance (in shares) at Nov. 29, 2025 |
|
|
|
|
14,519
|
3,551
|
|
|
|
|
|
| Beginning balance at Nov. 29, 2025 |
|
2,162,598
|
|
|
$ 1,452
|
$ 355
|
107,058
|
2,077,625
|
|
|
(23,892)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
20,484
|
|
|
|
|
|
20,484
|
|
|
|
| Change in fair value of derivatives |
[1] |
(29)
|
|
|
|
|
|
|
|
|
(29)
|
| Foreign currency translation |
|
3,881
|
|
|
|
|
|
|
|
|
3,881
|
| Dividends declared Common Stock |
|
|
(5,303)
|
(1,037)
|
|
|
|
|
(5,303)
|
(1,037)
|
|
| Share-based compensation, net |
[2] |
2,697
|
|
|
|
|
2,697
|
|
|
|
|
| Share-based awards exercised, net (in shares) |
[1] |
|
|
|
9
|
|
|
|
|
|
|
| Share-based awards exercised, net |
[1] |
1
|
|
|
$ 1
|
|
|
|
|
|
|
| Ending balance (in shares) at Feb. 28, 2026 |
|
|
|
|
14,528
|
3,551
|
|
|
|
|
|
| Ending balance at Feb. 28, 2026 |
|
2,183,292
|
|
|
$ 1,453
|
$ 355
|
109,755
|
2,091,769
|
|
|
(20,040)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
19,916
|
|
|
|
|
|
19,916
|
|
|
|
| Change in fair value of derivatives |
[1] |
(11)
|
|
|
|
|
|
|
|
|
(11)
|
| Foreign currency translation |
|
(1,685)
|
|
|
|
|
|
|
|
|
(1,685)
|
| Dividends declared Common Stock |
|
|
$ (5,296)
|
$ (1,037)
|
|
|
|
|
$ (5,296)
|
$ (1,037)
|
|
| Share-based compensation, net |
[2] |
2,866
|
|
|
|
|
2,866
|
|
|
|
|
| Share-based awards exercised, net (in shares) |
[1] |
|
|
|
4
|
|
|
|
|
|
|
| Ending balance (in shares) at May. 30, 2026 |
|
|
|
|
14,532
|
3,551
|
|
|
|
|
|
| Ending balance at May. 30, 2026 |
|
$ 2,198,045
|
|
|
$ 1,453
|
$ 355
|
$ 112,621
|
$ 2,105,352
|
|
|
$ (21,736)
|
|
|